Caption Management’s Legend Biotech LEGN Stock Holding History

Caption Management’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$543K	Hold	30,000	–	–	﹤0.01%	1191
2025 Q4	$652K	Buy	30,000 +10,000	+50%	+$286K	﹤0.01%	1187
2025 Q3	$652K	Buy	+20,000	New	+$738K	0.01%	1236
2025 Q1	–	Sell	-50,000	Closed	-$1.63M	–	1816
2024 Q4	$1.63M	Sell	50,000 -10,000	-17%	-$414K	0.02%	777
2024 Q3	$2.92M	Buy	60,000 +35,000	+140%	+$1.86M	0.05%	447
2024 Q2	$1.11M	Sell	25,000 -4,900	-16%	-$226K	0.02%	639
2024 Q1	$1.68M	Buy	29,900 +4,900	+20%	+$295K	0.03%	586
2023 Q4	$1.5M	Sell	25,000 -27,500	-52%	-$1.74M	0.02%	696
2023 Q3	$3.53M	Buy	52,500 +22,500	+75%	+$1.56M	0.05%	420
2023 Q2	$2.07M	Buy	+30,000	New	+$1.96M	0.04%	486
2022 Q3	–	Sell	-47,900	Closed	-$2.63M	–	1701
2022 Q2	$2.63M	Buy	+47,900	New	+$2.02M	0.04%	583
2021 Q4	–	Sell	-30,000	Closed	-$1.52M	–	1783
2021 Q3	$1.52M	Sell	30,000 -15,000	-33%	-$624K	0.02%	882
2021 Q2	$1.85M	Buy	+45,000	New	+$1.53M	0.02%	703

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FBIL

First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Caption Management's LEGN Position: Q1 2026 in Review

Caption Management opened a new position in Legend Biotech (LEGN) in Q1 2026: 15,500 shares worth $280K. The stake represents ﹤0.01% of the portfolio and ranks #1303 among its holdings. This is a return to the name: Caption Management previously reported a position in LEGN as recently as Q3 2025.

Caption Management first reported a position in LEGN in Q3 2022 and has held it in 6 quarters since. The position peaked at $2.52M in Q4 2022. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

Caption Management held 15,500 shares of Legend Biotech worth $280K as of Q1 2026.
Legend Biotech was a new Caption Management position in Q1 2026.
Legend Biotech made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1303 holding.
Caption Management first reported a position in Legend Biotech in Q3 2022 and has held it in 6 quarters since.
Caption Management's Legend Biotech position peaked at $2.52M in Q4 2022.
189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.